Metastatic Castration-resistant Prostate Cancer — Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations
Citation(s)
A Multicenter, Open-Label, Exploratory Platform Study to Evaluate Biomarkers and Immunotherapy Combinations for the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer